Medicare Enrolled

Dr. Randy Rozean, MD

Family Medicine · Lubbock, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
5815 82ND ST, Lubbock, TX 79424
8067943000
In practice since 2006 (19 years)
NPI: 1932163003 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rozean from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rozean? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rozean

Dr. Randy Rozean is a family medicine in Lubbock, TX, with 19 years in practice. Based on federal Medicare data, Dr. Rozean performed 3,207 Medicare services across 2,234 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rozean received a total of $11,039 from 51 pharmaceutical and/or device companies across 736 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rozean is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 7% volume in TX$ $11,039 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,207
Medicare services
Top 7% in TX for family medicine
2,234
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~169 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)843$78$172
Blood draw (venipuncture)554$8$18
Office visit, established patient (20-29 min)325$61$111
Chest X-ray, 2 views223$15$108
Annual wellness visit, follow-up204$124$150
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza145$54$257
Steroid injection (triamcinolone)99$1$40
Automated urinalysis83$2$9
Flu vaccine administration70$29$30
Flu vaccine, quadrivalent66$69$70
X-ray of lower and sacral spine, 2-3 views57$19$114
Ceftriaxone antibiotic injection45$0$120
Injection, methylprednisolone acetate, 80 mg43$7$18
Electrocardiogram (EKG), 12-lead42$9$80
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit42$158$250
Hip X-ray, 2-3 views37$23$122
X-ray of abdomen, 2 views36$17$115
Shoulder X-ray, 2+ views32$18$96
X-ray of knee, 1-2 views31$15$88
Pneumonia vaccine administration30$29$30
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use27$283$690
X-ray of middle spine, 2 views26$16$111
Foot X-ray, 3+ views26$18$88
X-ray of upper spine, 2-3 views25$19$105
X-ray of ankle, minimum of 3 views20$21$88
Removal of impacted ear wax18$32$144
X-ray of hand, minimum of 3 views17$18$88
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg16$1$10
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment13$158$278
Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)12$16$60
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,039
Total received (2018-2024)
Avg $1,577/year across 7 years
Top 4% in TX for family medicine
51
Companies
736
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,039 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,905
2023
$2,251
2022
$1,479
2021
$1,207
2020
$1,078
2019
$1,370
2018
$1,747

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,562
PFIZER INC.
$1,135
Lilly USA, LLC
$1,045
AbbVie Inc.
$681
GlaxoSmithKline, LLC.
$663
ABBVIE INC.
$632
Boehringer Ingelheim Pharmaceuticals, Inc.
$496
Merck Sharp & Dohme Corporation
$416
Abbott Laboratories
$367
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$348
Novo Nordisk Inc
$311
E.R. Squibb & Sons, L.L.C.
$296
Astellas Pharma US Inc
$280
AbbVie, Inc.
$247
Bayer Healthcare Pharmaceuticals Inc.
$219
Biohaven Pharmaceuticals, Inc.
$199
Amarin Pharma Inc.
$199
Bayer HealthCare Pharmaceuticals Inc.
$181
Exact Sciences Corporation
$167
Biohaven Pharmaceutical Holding Company Ltd.
$146
Amgen Inc.
$136
Genentech USA, Inc.
$122
Allergan Inc.
$118
Esperion Therapeutics, Inc.
$116
Avanir Pharmaceuticals, Inc.
$104
Novartis Pharmaceuticals Corporation
$89
Allergan, Inc.
$78
Orexigen Therapeutics, Inc.
$68
Supernus Pharmaceuticals, Inc.
$64
Dexcom, Inc.
$56
Tactile Systems Technology Inc
$47
Janssen Pharmaceuticals, Inc
$40
Kowa Pharmaceuticals America, Inc.
$38
SANOFI-AVENTIS U.S. LLC
$36
Boston Scientific Corporation
$32
Lundbeck LLC
$30
MannKind Corporation
$27
Mylan Specialty L.P.
$26
Daiichi Sankyo Inc.
$25
Antares Pharma, Inc.
$25
Insulet Corporation
$24
EISAI INC.
$24
Radius Health, Inc.
$18
Merck Sharp & Dohme LLC
$16
Takeda Pharmaceuticals U.S.A., Inc.
$15
Becton, Dickinson and Company
$14
Sanofi Pasteur Inc.
$14
Paratek Pharmaceuticals, Inc.
$13
Alfasigma USA, Inc.
$12
Nalpropion Pharmaceuticals, Inc.
$12
Eisai Inc.
$11
Top 3 companies account for 33.9% of total payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AREXVY · Aimovig · Androgel · BASAGLAR · BD Onclarity · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · Belviq · CAMZYOS · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · CREON · Cologuard Collection Kit · Creon · DIFICID · Dexcom G6 Transmitter · Dexilant · ELIQUIS · EMGALITY · ENTRESTO · FARXIGA · FLEXITOUCH · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · INJECTAFER · INVOKANA · JANUMET XR · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NEXLIZET · NUEDEXTA · NURTEC ODT · NUZYRA · NovoLog · OFEV · Omnipod · Otezla · Ozempic · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · QULIPTA · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Synthroid · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TROKENDI XR · TRULANCE · TRULICITY · Tresiba · Tymlos · UBRELVY · VIBERZI · VRAYLAR · VYEPTI · Vascepa · Veozah · Victoza · WATCHMAN FLX · XARELTO · XIFAXAN · XIGDUO · XYOSTED · Xofluza · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine in TX.

Equivalent to $344 per 100 Medicare services performed
Looking for a family medicine in Lubbock?
Compare family medicines in the Lubbock area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
111
Per 100K population
35.3
County median income
$63,367
Nearest hospital
EXCEPTIONAL COMMUNITY HOSPITAL LUBBOCK
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rozean is a clinical cardiology specialist, with above-average Medicare volume (top 7% in TX), and high industry engagement (low-engagement, top 4%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rozean experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rozean performed 843 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rozean receive payments from pharmaceutical companies?
Yes. Dr. Rozean received a total of $11,039 from 51 companies across 736 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rozean's costs compare to other family medicines in Lubbock?
Dr. Rozean's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rozean) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →